Tomohiro Kubota

Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Masaki Shimizu, Yasuo Nakagishi, Natsumi Inoue et al. · Clinical Immunology · 2015 · 175 citations

Life Sciences, Immunology, Pathobiology +14

Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation

Hiroshi Nihira, Kazushi Izawa, Moeko Ito et al. · Journal of Allergy and Clinical Immunology · 2021 · 51 citations

Life Sciences, Immunology, Molecular Biology +15

19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.

Tomohiro Kubota, Kozo Koshizuka, Manabu Koike et al. · PubMed · 1998 · 49 citations

Medicine, Oncology, Pharmacology +14

Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018

Nami Okamoto, Shumpei Yokota, Syuji Takei et al. · Modern Rheumatology · 2018 · 49 citations

Medicine, Infectious Diseases, Pediatrics +12

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Masaki Shimizu, Mao Mizuta, Nami Okamoto et al. · Pediatric Rheumatology · 2020 · 47 citations · Full text

Medicine, Immunology, Pediatrics +16